Status:
COMPLETED
3D Printed Mask for GBM and Brain Mets
Lead Sponsor:
University Health Network, Toronto
Conditions:
Brain Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a single site, investigator initiated study that aims to explore the feasibility of using a personalized 3D printed immobilization mask for CNS patients undergoing radiation therapy. For the ...
Detailed Description
All patients referred for radiotherapy have had a previous diagnostic imaging study (CT-scan or more commonly MRI) showing the disease at the central nervous system (CNS). Moreover, after surgical bio...
Eligibility Criteria
Inclusion
- Age \>18 years
- Patient with high-grade glioma considered for external beam radiotherapy (15 fractions or more) with or without Temozolamide, or patients with brain metastases considered for fractionated LINAC-based external beam radiotherapy (5 fractions or more) as primary or adjuvant treatment.
- No contraindications to MRI
- No other medical conditions deemed by the PI to make patient ineligible for the study (i.e. claustrophobia, confusion, delirium).
Exclusion
- None
Key Trial Info
Start Date :
September 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 18 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04114786
Start Date
September 26 2019
End Date
October 18 2022
Last Update
October 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Cancer Centre
Toronto, Ontario, Canada, M5G 2M9